Randomized controlled trial comparing gastric cancer screening by gastrointestinal X-ray with serology for Helicobacter pylori and pepsinogens followed by gastrointestinal endoscopy

Gastric Cancer

Volumn 18, Issue 3, 2015, Pages 605-611

  Gotoda, Takuji ^a   Ishikawa, Hideki ^b   Ohnishi, Hirohide ^c   Sugano, Kentaro ^d   Kusano, Chika ^a   Yokoi, Chizu ^e   Matsuyama, Yutaka ^f   Moriyasu, Fuminori ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^c AKITA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d JICHI MEDICAL UNIVERSITY   (Japan)

^e NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^f UNIVERSITY OF TOKYO   (Japan)

Author keywords

Gastric cancer; Gastrointestinal endoscopy; Gastrointestinal X ray; Randomized controlled trial; Serological testing

Indexed keywords

BARIUM; PEPSINOGEN;

ADULT; AGED; ARTICLE; CANCER SCREENING; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; FEASIBILITY STUDY; FEMALE; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL RADIOGRAPHY; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PULMONARY ASPIRATION; RANDOMIZED CONTROLLED TRIAL; REFUSAL TO PARTICIPATE; SEROLOGY; STOMACH CANCER; ABDOMINAL RADIOGRAPHY; BLOOD; COMPARATIVE STUDY; COMPLICATION; EARLY CANCER DIAGNOSIS; GASTROSCOPY; HELICOBACTER INFECTIONS; IMMUNOLOGY; MICROBIOLOGY; MIDDLE AGED; PATHOGENICITY; RADIOGRAPHY; STOMACH NEOPLASMS;

ADULT; AGED; EARLY DETECTION OF CANCER; FEMALE; GASTROSCOPY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; PEPSINOGENS; RADIOGRAPHY, ABDOMINAL; STOMACH NEOPLASMS;

EID: 84938894190     PISSN: 14363291     EISSN: 14363305     Source Type: Journal    
DOI: 10.1007/s10120-014-0408-5     Document Type: Article

References (38)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108.
2. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002. Cancer incidence, mortality and prevalence worldwide. IARC Cancer Base No. 5, version 2.0. Lyon: IARC Press, 2004.
3. International Agency for Research on Cancer. GLOBOCAN 2008. http://globocan.iarc.fr/.
4. National Cancer Center, Center for Cancer Control and Information Services. http://ganjoho.ncc.go.jp/professional/statistics/index.html.
5. Hisamichi Y, Nishino Y, Hisamichi S. Screening for gastric cancer. World J Surg. 1989;13:31–7.
6. Tsubono Y, Nishino Y, Hisamichi S. Screening for gastric cancer in Miyagi, Japan: evaluation with a population-based cancer registry. Asian Pac J Cancer Prev. 2000;1:57–60.
7. Shiratori Y, Nakagawa S, Kikuchi A, Ishii M, Ueno M, Miyashita T, et al. Significance of a gastric mass screening survey. Am J Gastroenterol. 1985;80:831–4.
8. Tsubono Y, Nishino Y, Hisamichi S. Screening for gastric cancer in Japan. Gastric Cancer. 2000;3:9–18.
9. Hamashima C, Shibuya D, Yamazaki H, Inoue K, Fukao A, Saito H, et al. The Japanese guideline for gastric cancer screening. Jpn J Clin Oncol. 2008;38:259–67.
10. Sobue T, Fukao A, Tsuji I, Ohnuki K, Sagawa M, Aoki D, et al. The Japanese Research Group for Development of Cancer Screening Guideline. Japanese guideline for gastric (stomach) cancer screening. (In Japanese). Tokyo: The Japanese Ministry of Health, Labour and Welfare; 2006.
11. Personnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med. 1991;325:1127–31.
12. Nomura A, Stemmermann GN, Chyou PH, Kato I, Perez-Perez GI, Blaser MJ. Helicobacter pylori infection and gastric carcinoma among Japanese American in Hawaii. N Engl J Med. 1991;325:1132–6.
13. Hirata Y, Maeda S, Mitsuno Y, Takeishi K, Yanai A, Akanuma M, et al. Helicobacter pylori CagA protein activates serum response element-driven transcription independently of tyrosine phosphorylation. Gastroenterology. 2002;123:1962–71.
14. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process-First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res. 1992;52:6735–40.
15. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001;345:784–9.
16. Huang JQ, Scridhar S, Chen Y, Hung RH. Meta-analysis of the relationship between elicobacter pylori seropositivity and gastric cancer. Gastroenterology. 1998;114:1169–79.
17. Naylor GM, Gotoda T, Dixon M, Shimoda T, Gatta L, Owen R, et al. Why does Japan have a high incidence of gastric cancer? Comparison of gastritis between UK and Japanese patients. Gut. 2006;55:1545–52.
18. Samloff IM, Varis K, Ihamaki T, Siurala M, Rotter JI. Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology. A study in relatives of patients with pernicious anemia. Gastroenterology. 1982;83:204–9.
19. Yoshihara M, Hiyama T, Yoshida S, Ito M, Tanaka S, Watanabe Y, et al. Reduction in gastric cancer mortality by screening based on serum pepsinogen concentration: a case-control study. Scand J Gastroenterol. 2007;42:760–4.
20. Yamaji Y, Mitsushima T, Ikuma H, Okamoto M, Yoshida H, Kawabe T, et al. Inverse background of Helicobacter pylori antibody and pepsinogen in reflux oesophagitis compared with gastric cancer: analysis of 5732 Japanese subjects. Gut. 2001;49:335–40.
21. Watabe H, Mitsushima T, Yamaji Y, Okamoto M, Wada R, Kokubo T, et al. Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study. Gut. 2005;54:764–8.
22. Guidelines for standard method of stomach radiography (in Japanese). J Gastroenterol Mass Surv. 2002;40:437–447.
23. Bhandari P, Green S, Hamanaka H, Nakajima T, Matsuda T, Saito Y, et al. Use of Gascon and Pronase either as apre-endoscopic drink or as targeted endoscopic flushes to improve visibility during gastroscopy: aprospective, randomized, controlled, blinded trial. Scand J Gastroenterol. 2010;45:357–61.
24. Asaka M, Kato M, Graham DY. Strategy for eliminating gastric cancer in Japan. Helicobacter. 2010;15:486–90.
25. Miki K, Ichinose M, Kakei N, Yahagi N, Matsushima M, Tsukada S, et al. The clinical application of the serum pepsinogen I and II levels as a mass screening method for gastric cancer. Adv Exp Med Biol. 1995;362:139–43.
26. Watanabe Y, Kurata JH, Mizuno S, Mukai M, Inokuchi H, Miki K, et al. Helicobacter pylori infection and gastric cancer. A nested case-control study in a rural area of Japan. Dig Dis Sci. 1997;42:1383–7.
27. Leung WK, Wu MS, Kakugawa Y, Kim JJ, Yeoh KG, Goh KL, et al. Screening for gastric cancer in Asia: current evidence and practice. Lancet Oncol. 2008;9:279–87.
28. Yang L. Incidence and mortality of gastric cancer in China. World J Gastroenterol. 2006;12:17–20.
29. Wittes RE, Friedman MA. Accrual to clinical trials. J Natl Cancer Inst. 1988;80:884–5.
30. Kunisaki C, Ishino J, Nakajima S, Motohashi H, Akiyama H, Nomura M, et al. Outcomes of mass screening for gastric carcinoma. Ann Surg Oncol. 2006;13:221–8.
31. Foundation for Promotion of Cancer Research. Cancer statistics in Japan—2012. Tokyo, Japan.
32. Suzuki H, Gotoda T, Sasako M, Saito D. Detection of early gastric cancer: misunderstanding the role of mass screening. Gastric Cancer. 2006;9:315–9.
33. Tashiro A, Sano M, Kinameri K, Fujita K, Takeuchi Y. Comparing mass screening techniques for gastric cancer in Japan. World J Gastroenterol. 2006;12:4874–5.
34. Dan YY, So JB, Yeoh KG. Endoscopic screening for gastric cancer. Clin Gastroenterol Hepatol. 2006;4:709–16.
35. Riecken B, Pfeiffer R, Ma JL, Jin ML, Li JY, Liu WD, et al. No impact of repeated endoscopic screening on gastric cancer mortality in a prospectively followed Chinese population at high risk. Prev Med. 2002;34:22–8.
36. Choi IJ. Screening and surveillance of gastric cancer. Korean J Gastroenterol. 2007;49(suppl):15–22.
37. Goh KL, Cheah PL, Md N, Quek KF, Parasakthi N. Ethnicity and H. pylori as risk factors for gastric cancer in Malaysia: a prospective case control study. Am J Gastroenterol. 2007;102:40–5.
38. National Registry of Diseases Office. Singapore Cancer Registry Interim Report. Trends in cancer incidence in Singapore 2001–2005. http://www.hpb.gov.sg/nrdo/files/Cancer%20reports/Cancer%20interim%20report%20v3%2001-05_for%20web.pdf. Accessed 5 Feb 2008.